http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010119466-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0094 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H5-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J17-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H11-00 |
filingDate | 2008-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2010119466-A |
titleOfInvention | NEW SULFATED OLIGOSACCHARIDES DERIVATIVES |
abstract | 1. The compound of the General formula:! ! in which each of X and Y represents a monosaccharide unit in which each hydroxyl group not participating in the glycosidic bond is independently substituted by a SO3M or H group, where M is any pharmaceutically acceptable cation; ! X and Y are any D- or L-hexose or pentose; ! Y is in the form of a closed or open cycle; ! Z represents O, N, S or C, or states of their higher oxidation state, or bond, and is bonded to the anomeric carbon atom when Y is a reducing monosaccharide; ! R1 is a linker selected from the group consisting of alkyl, alkenyl, alkynyl, aryl, heteroalkyl, heteroaryl, acyl, aroyl, alkylamido, alkylthioamido, triazolyl, substituted triazolyl, or is a bond; ! R2 is a lipophilic group selected from the group consisting of cholesteryl, cholestanyl, cholate, deoxycholate, glycyrrhetinyl, linear alkyl larger than C8, substituted alkyl larger than C8, alkylamido, substituted alkylamido, linear acyl, branched acyl, substituted acyl; ! n is an integer from 0 to 6; ! the degree of sulfation of each compound is in the range from 70 to 100% of the total number of hydroxyl groups, and! if R1 is a bond, then R2 is not glycyrrhetinic acid or its derivatives; ! if R1 is a bond, and n = 0 or 1, and Z is S, then R2 is not a C18 linear alkyl group; ! if n is 3-6, and R1 is a bond, and X and Y are α (1 → 4) -linked glucose, then R2 is not a C12-C18 linear alkyl group; ! if n is 3-5, and R1 is a bond, and X and Y are β (1� |
priorityDate | 2007-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.